98308: A Phase III Randomized, Double-Blind, Placebo Controlled Trial of North American Ginseng Extract (CVT-E002; COLD-fX®) to Prevent Respiratory Infection and Reduce Antibiotic Use in Patients with Chronic Lymphocytic Leukemia (1 credit)

This study is permanently closed as of 01/01/2009. The accrual goal has been achieved. This study was terminated on 11/10/2011.

Appendices • Archived Amendments • Adverse Events

Last Updated 2/29/2012

Quick Reference

Research Base

Fax 336-716-6275

Phone 336-716-0891

2000 West First Street
Protocol Information Office
Suite 401
Winston-Salem, NC 27104

Locate Faculty

First Name Last Name Department

Keyword

e.g., "allergy," "diabetes"

Ways to Give

Web Design and Development by The Berndt Group

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.